PuSH - Publikationsserver des Helmholtz Zentrums München

Hoh, A.* ; Heeg, M.* ; Ni, Y.* ; Schuch, A.* ; Binder, B.* ; Hennecke, N.* ; Blum, H.E.* ; Nassal, M.* ; Protzer, U. ; Hofmann, M.* ; Urban, S.* ; Thimme, R.*

HBV-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in vitro.

J. Virol. 89, 7433-7438 (2015)
Postprint DOI PMC
Open Access Green
CD8(+) T cells are main effector lymphocytes in the control of hepatitis B virus (HBV) infection. However, limitations of model systems such as low infection rates restricted mechanistic studies of HBV-specific CD8(+) T cells. Here, we established a novel immunological cell culture model based on HBV-infected HepG2(hNTCP) cells that endogenously processed and presented viral antigens to HBV-specific CD8(+) T cells. This induced cytolytic and non-cytolytic CD8(+) T-cell effector functions and reduction of viral loads.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Viral Clearance; Hepatocytes; Lymphocytes; Expression; Lines; Vivo
ISSN (print) / ISBN 0022-538X
e-ISSN 1098-5514
Zeitschrift Journal of Virology
Quellenangaben Band: 89, Heft: 14, Seiten: 7433-7438 Artikelnummer: , Supplement: ,
Verlag American Society for Microbiology (ASM)
Verlagsort Washington
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)